• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经白塞病患者脑脊液中 BAFF 水平升高:BAFF 与进行性痴呆和精神病相关。

Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.

机构信息

Department of Rheumatology, Shimane University Faculty of Medicine, Shimane, Japan.

出版信息

Scand J Immunol. 2012 Jun;75(6):633-40. doi: 10.1111/j.1365-3083.2012.02694.x.

DOI:10.1111/j.1365-3083.2012.02694.x
PMID:22340436
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3437506/
Abstract

Neuro-Behçet's disease (NBD) is a serious complication of Behçet's disease. Generally, NBD patients with a chronic course are refractory to immunosuppressive treatment, resulting in the deterioration of personality. In this study, levels of B cell-activating factor belonging to the TNF family (BAFF) were measured in the cerebrospinal fluid (CSF) from 18 patients with NBD, 27 patients with epidemic aseptic meningitis (AM), 24 patients with multiple sclerosis (MS) and 34 healthy controls. BAFF levels in patients with NBD were significantly elevated compared with healthy controls, but showed no statistically significant elevation compared with either of the disease controls. In contrast, CSF IL-6 levels were slightly elevated in patients with NBD and significantly elevated in patients with AM and MS compared with healthy controls. Patients with NBD were subdivided into two groups according to their clinical course (eight patients with a slowly progressive course presenting with psychosis and dementia and 10 patients with an acute course including aseptic meningitis, brainstem involvement and myelopathy). BAFF levels were significantly increased in those with a slowly progressive course compared with those with an acute course. CSF BAFF levels did not correlate with serum BAFF levels, CSF cell counts or CSF IL-6 levels in patients with NBD. These data suggested that BAFF was produced within the central nervous system and may be associated with the development of NBD, particularly with a progressive course.

摘要

神经白塞病(NBD)是白塞病的严重并发症。一般来说,NBD 患者病程呈慢性,对免疫抑制治疗反应差,导致人格恶化。在这项研究中,我们测量了 18 例 NBD 患者、27 例流行性无菌性脑膜炎(AM)患者、24 例多发性硬化症(MS)患者和 34 例健康对照者的脑脊液(CSF)中 B 细胞激活因子属于 TNF 家族(BAFF)的水平。与健康对照组相比,NBD 患者的 BAFF 水平显著升高,但与任何疾病对照组相比均无统计学意义上的升高。相比之下,NBD 患者的 CSF IL-6 水平略有升高,而 AM 和 MS 患者则明显高于健康对照组。根据临床病程,将 NBD 患者分为两组(8 例缓慢进展型患者表现为精神病和痴呆,10 例急性型患者包括无菌性脑膜炎、脑干受累和脊髓病变)。与急性病程患者相比,缓慢进展型患者的 BAFF 水平显著升高。NBD 患者的 CSF BAFF 水平与血清 BAFF 水平、CSF 细胞计数或 CSF IL-6 水平均无相关性。这些数据表明,BAFF 是在中枢神经系统内产生的,可能与 NBD 的发生,特别是与进展性病程有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2079/3437506/43eb925100e2/sji0075-0633-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2079/3437506/de2bbf1b875a/sji0075-0633-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2079/3437506/2ecb4235ee61/sji0075-0633-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2079/3437506/43eb925100e2/sji0075-0633-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2079/3437506/de2bbf1b875a/sji0075-0633-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2079/3437506/2ecb4235ee61/sji0075-0633-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2079/3437506/43eb925100e2/sji0075-0633-f3.jpg

相似文献

1
Elevated BAFF levels in the cerebrospinal fluid of patients with neuro-Behçet's disease: BAFF is correlated with progressive dementia and psychosis.神经白塞病患者脑脊液中 BAFF 水平升高:BAFF 与进行性痴呆和精神病相关。
Scand J Immunol. 2012 Jun;75(6):633-40. doi: 10.1111/j.1365-3083.2012.02694.x.
2
BAFF is up-regulated in central nervous system of neuro-Behçet's disease.在神经白塞病的中枢神经系统中,B细胞激活因子(BAFF)表达上调。
J Neuroimmunol. 2008 Aug 30;200(1-2):111-4. doi: 10.1016/j.jneuroim.2008.06.006. Epub 2008 Jul 14.
3
Decreased Level of IL-37 Correlates Negatively with Inflammatory Cytokines in Cerebrospinal Fluid of Patients with Neuro-Behcet's Disease.神经白塞病患者脑脊液中白细胞介素-37水平降低与炎性细胞因子呈负相关。
Iran J Immunol. 2019 Dec;16(4):299-310. doi: 10.22034/IJI.2019.80281.
4
[Recent aspects of Neuro-Behcet's disease].[神经白塞病的近期研究进展]
Brain Nerve. 2013 Nov;65(11):1245-53.
5
Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's Disease.脑脊液中T-bet/GATA-3和ROR-γt/Foxp3比值升高作为确诊神经白塞病的潜在标准
J Clin Med. 2022 Jul 29;11(15):4415. doi: 10.3390/jcm11154415.
6
Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis.日本神经白塞病的临床特征:一项多中心回顾性分析。
Mod Rheumatol. 2012 Jun;22(3):405-13. doi: 10.1007/s10165-011-0533-5. Epub 2011 Sep 21.
7
Increased IL-22 in cerebrospinal fluid of neuro-behçet's disease patients.神经白塞病患者脑脊液中白细胞介素 22 增加。
Cytokine. 2024 Jul;179:156617. doi: 10.1016/j.cyto.2024.156617. Epub 2024 Apr 16.
8
Cerebrospinal fluid interleukin-6 in progressive Neuro-Behçet's syndrome.进行性神经白塞病综合征中的脑脊液白细胞介素-6
Clin Immunol Immunopathol. 1997 Jan;82(1):12-7. doi: 10.1006/clin.1996.4268.
9
Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis.英夫利昔单抗治疗神经贝赫切特病急性起病可逆性痴呆:病例报告及细胞因子分析。
J Neuroimmunol. 2021 Aug 15;357:577631. doi: 10.1016/j.jneuroim.2021.577631. Epub 2021 Jun 8.
10
Changes in biomarkers focused on differences in disease course or treatment in patients with neuro-Behçet's disease.生物标志物的变化聚焦于神经白塞病患者疾病进程或治疗方面的差异。
Intern Med. 2012;51(24):3359-65. doi: 10.2169/internalmedicine.51.8583. Epub 2012 Dec 15.

引用本文的文献

1
Comparative Analysis of Serum BAFF and IL-17 Levels Pre- and Post-Antipsychotic Treatment for Acute Schizophrenia.急性精神分裂症抗精神病药物治疗前后血清BAFF和IL-17水平的比较分析
Int J Mol Sci. 2025 Jan 4;26(1):385. doi: 10.3390/ijms26010385.
2
Neuro-Behçet's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis.神经白塞病:临床诊断、生物标志物及免疫发病机制的最新进展
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae123.
3
The relationship between chronic immune response and neurodegenerative damage in long COVID-19.

本文引用的文献

1
Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice.自身免疫倾向的 B 细胞激活因子转基因小鼠的成年神经发生减少和情绪行为改变。
Biol Psychiatry. 2010 Mar 15;67(6):558-66. doi: 10.1016/j.biopsych.2009.12.008.
2
[Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature].[白塞病的神经系统受累。来自925例患者队列中的154例病例及文献综述]
Rev Neurol (Paris). 2006 Nov;162(11):1084-90. doi: 10.1016/s0035-3787(06)75121-9.
3
Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease.
长新冠中慢性免疫反应与神经退行性损伤的关系。
Front Immunol. 2022 Dec 16;13:1039427. doi: 10.3389/fimmu.2022.1039427. eCollection 2022.
4
Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behçet's disease.脑脊液神经丝轻链水平与神经 Behcet 病的疾病活动增加有关。
Turk J Med Sci. 2022 Aug;52(4):1266-1273. doi: 10.55730/1300-0144.5432. Epub 2022 Aug 10.
5
B Cells Specific CpG Induces High IL-10 and IL-6 Expression In Vitro in Neuro-Behçet's Disease.B 细胞特异性 CpG 体外诱导神经白塞病中高表达 IL-10 和 IL-6。
Cells. 2022 Apr 12;11(8):1306. doi: 10.3390/cells11081306.
6
Increased vitreous levels of B cell activation factor (BAFF) and soluble interleukin-6 receptor in patients with macular edema due to uveitis related to Behçet's disease and sarcoidosis.葡萄膜炎相关性贝赫切特病和结节病所致黄斑水肿患者玻璃体内 B 细胞激活因子 (BAFF) 和可溶性白细胞介素-6 受体水平升高。
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2675-2686. doi: 10.1007/s00417-022-05600-1. Epub 2022 Mar 1.
7
Rapamycin Modulates the Proinflammatory Memory-Like Response of Microglia Induced by BAFF.雷帕霉素调节 BAFF 诱导的小胶质细胞的促炎记忆样反应。
Front Immunol. 2021 May 12;12:639049. doi: 10.3389/fimmu.2021.639049. eCollection 2021.
8
Association between dementia and systemic rheumatic disease: A nationwide population-based study.痴呆与系统性风湿性疾病的关联:一项全国性基于人群的研究。
PLoS One. 2021 Mar 12;16(3):e0248395. doi: 10.1371/journal.pone.0248395. eCollection 2021.
9
Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.与抗中性粒细胞胞质抗体相关的肥厚性硬脑膜炎发病机制相关的脑脊液生物标志物。
Clin Rheumatol. 2020 Jun;39(6):1803-1811. doi: 10.1007/s10067-020-04971-2. Epub 2020 Feb 8.
10
Clinical and Radiographic Characteristics of Neuro-Behçet's Disease in South Korea.韩国神经白塞病的临床和影像学特征
J Clin Neurol. 2019 Oct;15(4):429-437. doi: 10.3988/jcn.2019.15.4.429.
白塞病患者血清和脑脊液中白细胞介素-15的水平。
Scand J Immunol. 2006 Dec;64(6):655-60. doi: 10.1111/j.1365-3083.2006.01844.x.
4
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.肿瘤坏死因子家族的B细胞激活因子(BAFF)在原发性干燥综合征患者的唾液腺上皮细胞中受干扰素刺激后表达。
Arthritis Res Ther. 2006;8(2):R51. doi: 10.1186/ar1912. Epub 2006 Feb 28.
5
Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF.血清细胞因子和BAFF揭示的伴有异位唾液腺生发中心的干燥综合征患者的不同特征。
Clin Immunol. 2005 Nov;117(2):168-76. doi: 10.1016/j.clim.2005.06.016. Epub 2005 Aug 26.
6
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma.B淋巴细胞刺激因子由星形胶质细胞产生,在多发性硬化症病变和原发性中枢神经系统淋巴瘤中上调。
J Exp Med. 2005 Jan 17;201(2):195-200. doi: 10.1084/jem.20041674. Epub 2005 Jan 10.
7
The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.BAFF/APRIL系统在B细胞稳态和淋巴样癌症中的作用。
Curr Opin Pharmacol. 2004 Aug;4(4):347-54. doi: 10.1016/j.coph.2004.02.009.
8
Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.B细胞淋巴瘤通过肿瘤坏死因子家族成员BAFF/BLyS和APRIL逃避细胞凋亡。
J Immunol. 2004 Mar 1;172(5):3268-79. doi: 10.4049/jimmunol.172.5.3268.
9
G-CSF-stimulated neutrophils are a prominent source of functional BLyS.粒细胞集落刺激因子(G-CSF)刺激的中性粒细胞是功能性B淋巴细胞刺激因子(BLyS)的主要来源。
J Exp Med. 2003 Feb 3;197(3):297-302. doi: 10.1084/jem.20021343.
10
Oligoclonal B lymphocyte expansion in the synovium of a patient with Behçet's disease.白塞病患者滑膜中寡克隆B淋巴细胞增殖。
Arthritis Rheum. 2001 Jul;44(7):1707-12. doi: 10.1002/1529-0131(200107)44:7<1707::AID-ART295>3.0.CO;2-P.